JP2024545170A5 - - Google Patents
Info
- Publication number
- JP2024545170A5 JP2024545170A5 JP2024534514A JP2024534514A JP2024545170A5 JP 2024545170 A5 JP2024545170 A5 JP 2024545170A5 JP 2024534514 A JP2024534514 A JP 2024534514A JP 2024534514 A JP2024534514 A JP 2024534514A JP 2024545170 A5 JP2024545170 A5 JP 2024545170A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111507685.5 | 2021-12-10 | ||
| CNPCT/CN2021/136994 | 2021-12-10 | ||
| CN202111507685 | 2021-12-10 | ||
| PCT/CN2021/136994 WO2023102875A1 (en) | 2021-12-10 | 2021-12-10 | Anti-cdh6 antibody drug conjugate |
| PCT/CN2022/137932 WO2023104188A1 (en) | 2021-12-10 | 2022-12-09 | Anti-cdh6 antibodies and antibody-drug conjugates thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024545170A JP2024545170A (ja) | 2024-12-05 |
| JPWO2023104188A5 JPWO2023104188A5 (https=) | 2025-12-08 |
| JP2024545170A5 true JP2024545170A5 (https=) | 2025-12-08 |
Family
ID=86729685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024534514A Pending JP2024545170A (ja) | 2021-12-10 | 2022-12-09 | 抗ｃｄｈ６抗体及びその抗体薬物複合体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250090677A1 (https=) |
| EP (1) | EP4444360A1 (https=) |
| JP (1) | JP2024545170A (https=) |
| KR (1) | KR20240130160A (https=) |
| CN (1) | CN118302199A (https=) |
| AU (1) | AU2022406708A1 (https=) |
| CA (1) | CA3239715A1 (https=) |
| IL (1) | IL313227A (https=) |
| MX (1) | MX2024007035A (https=) |
| TW (1) | TW202330618A (https=) |
| WO (1) | WO2023104188A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2024190815A1 (https=) | 2023-03-14 | 2024-09-19 | ||
| TW202444427A (zh) | 2023-03-31 | 2024-11-16 | 日商第一三共股份有限公司 | 抗CDH6抗體-藥物結合物與HIF-2α抑制劑之組合 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016169581A1 (en) * | 2015-04-20 | 2016-10-27 | Consejo Superior De Investigaciones Científicas | Agents binding specifically to human cadherin-17, human cadherin-5, human cadherin-6 and human cadherin-20 rgd motif |
| WO2018185618A1 (en) * | 2017-04-03 | 2018-10-11 | Novartis Ag | Anti-cdh6 antibody drug conjugates and anti-gitr antibody combinations and methods of treatment |
| TW202532102A (zh) * | 2017-05-15 | 2025-08-16 | 日商第一三共股份有限公司 | 抗體－藥物結合物及其用途 |
| JP7401456B2 (ja) * | 2018-11-14 | 2023-12-19 | 第一三共株式会社 | 抗ｃｄｈ６抗体－ピロロベンゾジアゼピン誘導体コンジュゲート |
-
2022
- 2022-12-09 AU AU2022406708A patent/AU2022406708A1/en active Pending
- 2022-12-09 CN CN202280076590.9A patent/CN118302199A/zh active Pending
- 2022-12-09 US US18/715,982 patent/US20250090677A1/en active Pending
- 2022-12-09 CA CA3239715A patent/CA3239715A1/en active Pending
- 2022-12-09 IL IL313227A patent/IL313227A/en unknown
- 2022-12-09 MX MX2024007035A patent/MX2024007035A/es unknown
- 2022-12-09 JP JP2024534514A patent/JP2024545170A/ja active Pending
- 2022-12-09 KR KR1020247022271A patent/KR20240130160A/ko active Pending
- 2022-12-09 TW TW111147444A patent/TW202330618A/zh unknown
- 2022-12-09 WO PCT/CN2022/137932 patent/WO2023104188A1/en not_active Ceased
- 2022-12-09 EP EP22903605.8A patent/EP4444360A1/en active Pending